Presentation Information
[[OD]1S10a-4]Mechanisms and treatments for disorders caused by abnormal activation of the type 2 ryanodine receptor (RyR2)
○Nagomi Kurebayashi (Dept Pharmacol, Juntendo Univ Fac Med)
Comment
To browse or post comments, you must log in.Log in